You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 126 No. 10, October 1990 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  STUDIES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (11)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Response of Black and White Guinea Pig Skin to Photodynamic Treatment Using 514-nm Light and Dihematoporphyrin Ether

Eric F. Bernstein, MD; Gunter F. Thomas; Paul D. Smith, PhD; James B. Mitchell, PhD; Eli Glatstein, MD, PhD; Gary R. Kantor, MD; Richard L. Spielvogel, MD; Susan C. Maiese, MD; Angelo Russo, MD, PhD

Arch Dermatol. 1990;126(10):1303-1307.


Abstract



• Differences in skin pigmentation may significantly affect light penetration during photodynamic therapy. This study evaluated the effect of skin pigmentation on dermatotoxic reaction to photodynamic therapy utilizing the photosensitizer dihematoporphyrin ether. Black and white guinea pigs were given 10 mg/kg of dihematoporphyrin ether, depilated, and treated 48 hours after injection with 30 mW/cm2 of 514-nm light. Eschar formation was observed on white skin at an average light dose of 26 J/cm2, whereas black skin showed similar changes at 58 J/cm2. Microscopically, superficial necrosis corresponded to the gross changes noted. Our results agree with data describing the difficulty of treating pigmented lesions such as malignant melanoma with photodynamic therapy. This further suggests that higher light doses may be required to treat superficial lesions and produce skin photosensitivity in dark-skinned individuals.

(Arch Dermatol. 1990;126:1303-1307)



Author Affiliations



From the Radiation Oncology Branch, National Cancer Institute (Drs Bernstein, Mitchell, Glatstein, and Russo and Mr Thomas), and the Bioengineering Division, National Institutes of Health (Dr Smith), Bethesda, Md; and the Division of Dermatology (Drs Bernstein, Kantor, and Spielvogel) and the Department of Pathology (Dr Maiese), Hahnemann University School of Medicine, Philadelphia, Pa.


Footnotes



Accepted for publication May 1, 1990.

Reprint requests to Division of Dermatology, Hahnemann University School of Medicine, Broad and Vine, M.S. 401, Philadelphia, PA 19102 (Dr Bernstein).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Photodynamic Therapy of Pigmented Choroidal Melanomas Using a Liposomal Preparation of Benzoporphyrin Derivative
Young et al.
Arch Ophthalmol 1996;114:186-192.
ABSTRACT  

Transcutaneous Determination of Tissue Dihematoporphyrin Ether Content: A Device to Optimize Photodynamic Therapy
Bernstein et al.
Arch Dermatol 1991;127:1794-1798.
ABSTRACT  

Efficiency of Opaque Photoprotective Agents in the Visible Light Range
Kaye et al.
Arch Dermatol 1991;127:351-355.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.